The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes

Recruiting now

Conditions studied: Cerebral Palsy, Multiple Sclerosis, Stroke, Neurologic Disorder, Fibromyalgia

In brief

The objective is to explore the potential short and long-term impact of the EXOPULSE Mollii Suit and EXOPULSE Suit on subjects with CP, MS, stroke, fibromyalgia or other neurologic disorders which may cause such types of symptoms, and to identify high responders among the sub-categories of the diagnoses. The primary endpoint will be improvements in the Berg/Pediatric Balance Scale (BBS/PBS) as a measurement of balance and risk of falls.

Key facts

Study ID

NCT05901259

Run by

Exoneural Network AB

People needed

200

Starts

2026-02-18

Expected to finish

2027-12-31

Last updated by the study team

2026-02-27

Who can join

Age: 2 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with CP, MS, stroke, fibromyalgia or other neurologic disorder that may cause such type of symptoms.
• Diagnosed >6 months prior to inclusion in case of MS or stroke as well as >1 month prior to inclusion in the case of fibromyalgia.
• Give written informed consent
• Cognitively able to understand and follow verbal and/or written instructions
• A minimum age of 2 years

You may not qualify if…

• Any of the contraindications listed in the instructions for use of the EXOPULSE Mollii Suit or EXOPULSE Suit
• Being introduced to any new medication affecting the neuromuscular activity during the study period
• Using botulinum toxin <3 month before or during the study period
• Subjects <100 cm and <13 kg
• Subjects >205 cm and >115 kg

Where it is running

• Ottobock Care Sverige — Bergshamra, Stockholm County, Sweden (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.